GRK2 and ischemia: Additionally, in transgenic models displaying increased cardiac GRK2, an impairment of the cardioprotective eNOS pathway and reduced NO bioavailability is observed in cardiac cells, thus promoting increased myocardial injury in ischemia/reperfusion mice models by mechanisms involving mutual inhibition of GRK2 and eNOS (Huang et al., 2013).